Search results
Results from the WOW.Com Content Network
COVID-19 portal. v. t. e. Total number of people who have received vaccinations in Thailand as of 8 Nov 2021 [1] * Percentage of population with right to medical treatment [2] Unvaccinated population: ~23.003 million people (34.24%) Population who have received only one dose of a two-dose vaccine: 9,745,446 (14.51%)
The COVID-19 vaccination in Spain is the national vaccination strategy started on 27 December 2020 in order to vaccinate the country's population against COVID-19 within the international effort to fight the COVID-19 pandemic . As of November 23, 2021, the following doses had been received: 59,296,575 Pfizer–BioNTech COVID-19 vaccine doses ...
German vaccination certificate with evidence of two-dose of COVID-19 vaccination There are several COVID-19 vaccines at various stages of development around the world. The ones listed as "pending" in the column "approval" in the table below were under review by the European Medicines Agency as of 15 May 2021, [6] with unclear status as of July ...
The COVID-19 pandemic in Pakistan is part of the ongoing pandemic of coronavirus disease 2019 ( COVID-19) caused by severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ). The virus was confirmed to have reached Pakistan on 26 February 2020, when two cases were recorded (a student in Karachi who had just returned from Iran and another ...
Sputnik V ( Russian: Спутник V, the brand name from the Russian Direct Investment Fund or RDIF) or Gam-COVID-Vac ( Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced [3]) is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and ...
The COVID‑19 vaccination programme in the United Kingdom prioritized elder care facility residents and carers, followed by healthcare workers and those over 80 years of age. Subsequent phases are based largely on age, declining from 75 years in 5-year increments.
t. e. COVID-19 vaccination in mainland China is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in mainland China, in response to the ongoing pandemic in the region . As of July 2022, it is estimated that about 89.7% of the country's population has received a vaccine, and about 56% of the ...
The vaccine may have characteristics favorable for vaccinating people in the developing world. While mRNA vaccines, such as the Pfizer–BioNTech COVID-19 vaccine and Moderna COVID-19 vaccine showed higher efficacy of +90%, mRNA vaccines present distribution challenges for some nations, as some may require deep-freeze facilities and trucks.